Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Eps8 Activators

Eps8 Activators encompass a collection of chemical compounds that enhance the functional activity of Eps8 through various signaling pathways and interactions with the actin cytoskeleton. Phalloidin and Jasplakinolide amplify Eps8's capping and bundling functions by stabilizing actin filaments, ensuring a robust architecture for cellular processes dependent on cytoskeletal dynamics. Blebbistatin and Cytochalasin D, by modulating actin-myosin interactions and inhibiting actin polymerization respectively, create conditions that favor the actin capping activity of Eps8, thus facilitating its role in actin filament maintenance and rearrangement. Latrunculin A, through its preferential binding to actin monomers, increases the pool of available G-actin, indirectly promoting the capping efficiency of Eps8, while Calyculin A, by inhibiting protein phosphatases, might lead to a phosphorylation state that favors Eps8's interaction with actin. ML141 and NSC23766, as inhibitors of the small GTPases CDC42 and Rac1, could potentially skew cellular signaling pathways towards those that enhance Eps8-mediated actin remodeling, integral to cellular protrusion formation and motility.

In addition, PDGF-BB, by activating growth factor signaling pathways, and Forskolin, by increasing intracellular cAMP levels, indirectly foster an environment conducive to Eps8's functional activity in actin reorganization. Manumycin A, through its inhibition of Ras farnesyltransferase, may also potentiate Eps8's role in signaling pathways that influence actin cytoskeletal rearrangements. The collective action of these compounds serves to potentiate the cellular functions of Eps8, specifically in the context of actin filament dynamics, without necessitating the upregulation of its expression or direct activation. This precise modulation of Eps8's activity by diverse chemical activators underscores the intricate regulatory mechanisms that govern cellular cytoskeletal dynamics and the potential for targeted intervention in pathways involving Eps8.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Phalloidin

17466-45-4sc-202763
1 mg
$234.00
33
(1)

Stabilizes actin filaments and prevents their disassembly, enhancing Eps8's role in actin filament capping.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

Stabilizes actin filaments, potentially increasing Eps8-mediated capping and bundling of actin structures.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that promotes actin cytoskeleton remodelling, potentially augmenting Eps8's actin-related roles.

(S)-(−)-Blebbistatin

856925-71-8sc-204253
sc-204253A
sc-204253B
sc-204253C
1 mg
5 mg
10 mg
25 mg
$72.00
$265.00
$495.00
$968.00
(2)

Inhibits myosin II, thus could enhance Eps8 activity in cells by affecting actin-myosin interactions.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Binds to actin monomers and prevents polymerization, possibly enhancing the capping ability of Eps8.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Inhibits actin polymerization and enhances Eps8's capping and bundling activity by increasing actin turnover.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

CDC42 inhibitor, potentially enhancing Eps8-mediated changes in the actin cytoskeleton.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

Inhibitor of Rac1, may synergize with Eps8's role in actin remodeling and cellular protrusions.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylyl cyclase increasing cAMP, which can indirectly enhance Eps8-mediated actin remodeling.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Inhibits protein phosphatases 1 and 2A, possibly resulting in enhanced Eps8 activity in actin dynamics.